1. Home
  2. RYZ vs EVO Comparison

RYZ vs EVO Comparison

Compare RYZ & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryerson Holding Corporation Common Stock

RYZ

Ryerson Holding Corporation Common Stock

N/A

Current Price

$26.40

Market Cap

1.0B

Sector

Industrials

ML Signal

N/A

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.13

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYZ
EVO
Founded
1842
1993
Country
United States
Germany
Employees
4300
4553
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
934.1M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
RYZ
EVO
Price
$26.40
$3.13
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
246.3K
97.7K
Earning Date
05-06-2026
04-08-2026
Dividend Yield
2.82%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$75.79
$1.37
Revenue Next Year
$2.17
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.34
$2.31
52 Week High
$28.26
$4.80

Technical Indicators

Market Signals
Indicator
RYZ
EVO
Relative Strength Index (RSI) 56.87 56.90
Support Level $23.68 $2.87
Resistance Level N/A $3.78
Average True Range (ATR) 1.08 0.11
MACD 0.20 -0.00
Stochastic Oscillator 59.31 45.10

Price Performance

Historical Comparison
RYZ
EVO

About RYZ Ryerson Holding Corporation Common Stock

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company has one operating and reportable segment, metals service centers. It derives substantially all of its sales from the processing and distribution of met. Geographically, the majority revenue is generated from the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: